Glenmark Pharmaceuticals
Nifty 200
Nifty 500
Midcap 100
Midcap 150
LargeMid 250
F&O
₹2,419.20
+0.17%
Delayed · cached 15 min
Frequently asked questions
What sector does Glenmark Pharmaceuticals belong to?
Glenmark Pharmaceuticals operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of GLENMARK?
As of the latest available quote, GLENMARK traded at ₹2,419.20. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of GLENMARK?
Glenmark Pharmaceuticals has a price-to-earnings (P/E) ratio of about 37.94. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of GLENMARK?
The market capitalisation of Glenmark Pharmaceuticals is approximately ₹68,784 Cr.
Is Glenmark Pharmaceuticals profitable?
For its latest reported financial year, Glenmark Pharmaceuticals recorded a net profit margin of about 8.02%.
Does GLENMARK pay a dividend?
Glenmark Pharmaceuticals currently has a dividend yield of about 0.10%.
What is the return on equity (ROE) of GLENMARK?
Glenmark Pharmaceuticals has a return on equity (ROE) of about 23.60%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of GLENMARK?
Over the past 52 weeks, GLENMARK has traded between a low of ₹1,792.60 and a high of ₹2,537.60.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.